Oliver Luxxe Assets’s Halozyme HALO Stock Holding History

Oliver Luxxe Assets’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.58M	Sell	33,014 -17,166	-34%	-$1.17M	0.38%	84
2026 Q1	$3.24M	Buy	50,180 +8,168	+19%	+$576K	0.49%	74
2025 Q4	$2.83M	Buy	42,012 +213	+0.5%	+$14.3K	0.43%	78
2025 Q3	$3.07M	Buy	41,799 +765	+2%	+$50.8K	0.49%	73
2025 Q2	$2.13M	Buy	41,034 +795	+2%	+$45.2K	0.38%	94
2025 Q1	$2.57M	Sell	40,239 -16,856	-30%	-$979K	0.48%	73
2024 Q4	$2.99M	Buy	57,095 +29,325	+106%	+$1.5M	0.26%	122
2024 Q3	$1.59M	Buy	+27,770	New	+$1.59M	0.28%	125

Other funds holding HALO

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAM

Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return

Cooper Investors Melbourne, Victoria, Australia $218M AUM 0.39% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return

Oliver Luxxe Assets's HALO Position: Q2 2026 in Review

Oliver Luxxe Assets reduced its Halozyme (HALO) stake by 34% in Q2 2026, selling an estimated $1.17M and leaving 33,014 shares worth $2.58M. The position accounts for 0.38% of the portfolio, ranked #84.

Oliver Luxxe Assets first reported a position in HALO in Q3 2024 and has held it in 8 quarters since. The position peaked at $3.24M in Q1 2026. 82 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Oliver Luxxe Assets held 33,014 shares of Halozyme worth $2.58M as of Q2 2026.
Oliver Luxxe Assets sold 17,166 Halozyme shares in Q2 2026, an estimated $1.17M.
Halozyme made up 0.38% of Oliver Luxxe Assets's portfolio in Q2 2026, its #84 holding.
Oliver Luxxe Assets first reported a position in Halozyme in Q3 2024 and has held it in 8 quarters since.
Oliver Luxxe Assets's Halozyme position peaked at $3.24M in Q1 2026.
82 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.